This effect might be mediated through the targeted silencing of BCL2, programmed cell death protein 4 (PDCD4), and Wilms tumour 1 (WT1) [59, 60], the latter of which is frequently detected at high levels in AML [60]. This evidence concerns the gene WT1 and acute myeloid leukemia.